1,2,4-Triazine Derivatives as NLRP3 Inhibitors for Treating Diseases

Ram W Sabnis

doi:10.1021/acsmedchemlett.3c00122

1,2,4-Triazine Derivatives as NLRP3 Inhibitors for Treating Diseases

ACS Med Chem Lett. 2023 Apr 12;14(5):547-548. doi: 10.1021/acsmedchemlett.3c00122. eCollection 2023 May 11.

Author

Ram W Sabnis¹

Affiliation

¹ Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.

Abstract

Provided herein are 1,2,4-triazine derivatives used as NLRP3 inhibitors, their pharmaceutical compositions, the use of such compounds in treating diseases and processes for preparing such compounds.

Published 2023 by American Chemical Society.

Publication types

Editorial